Explore our materials

European HIV Clinical Forum 2022

Update on Therapeutic Options for HIV Prevention - David Jilich, MD

Miłosz Parczewski

MD, PhD

European HIV Clinical Forum 2022

Clinical Case - Miłosz Parczewski, MD, PhD

Gary Rubin

MD, MCFP, AAHIVS

European HIV Clinical Forum 2022

Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs - Gary Rubin, MD, MCFP, AAHIVS

Esteban Martínez

MD, PhD

European HIV Clinical Forum 2022

Comorbidity and Toxicity Considerations in Choice of Regimen - Esteban Martinez, MD, PhD

Saye Khoo

MD, PhD

European HIV Clinical Forum 2022

Pharmacological Considerations in Choice of Regimen - Saye Khoo, MD, PhD

Daniele Armenia

PhD

European HIV Clinical Forum 2022

Resistance Considerations in Choice of Regimen - Daniele Armenia, PhD

Caroline Sabin

PhD

European HIV Clinical Forum 2022

International and European Guidelines - Similarities and Differences - Caroline Sabin, PhD

Beatrice Halpaap

Pharm D, MPH

APACC 2022

Social Innovations in Health, Especially with Implications for HIV and Other Co-Infections | Beatrice Halpaap, Pharm D, MPH

Steve McGloughlin

BSc, BMed, FCICM, FRACP, MPH&TM, PGDipEcho

APACC 2022

New Development of Therapeutics for COVID Treatment | Steve McGloughlin, Bsc, BMed, FCICM, FRACP, MPH&TM, PGDipEcho

Jennifer Hoy

MBBS, AM, FRACP, FAHMS

APACC 2022

New Antiretroviral Drugs/Formulations for the Treatment of PLWH and for Prevention of HIV | Jennifer Hoy, AM, FRACP, FAHMS

Chien-Ching Hung

MD, PhD

APACC 2022

Epidemiology of Hepatitis Delta in the Asian Region – Do We Need Screening & What Are the Treatment Options? | Chien-Ching Hung, MD, PhD

Hao Liang

MD, PhD